Skip to Content
MilliporeSigma
All Photos(2)

Key Documents

SAB4200295

Sigma-Aldrich

Anti-Glycogen Synthase 2 (C-terminal) antibody produced in rabbit

enhanced validation

~1.5 mg/mL, affinity isolated antibody

Synonym(s):

Anti-GYS2, Anti-Glycogen Synthase 2 (liver)

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
51111800
NACRES:
NA.41

biological source

rabbit

conjugate

unconjugated

antibody form

affinity isolated antibody

antibody product type

primary antibodies

clone

polyclonal

form

buffered aqueous solution

mol wt

antigen ~85 kDa (rat and mouse)
antigen ~95 kDa (human)

species reactivity

mouse, rat, human

enhanced validation

recombinant expression
Learn more about Antibody Enhanced Validation

concentration

~1.5 mg/mL

technique(s)

western blot: 1.5-3 μg/mL using extracts of mouse liver (S1 fraction), rat liver (S1 fraction) and of HEK-293T cells overexpressing human GYS2.

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

human ... GYS2(2998)
mouse ... Gys2(232493)
rat ... Gys2(25623)

General description

The glycogen synthase 2 (GYS2) gene is mapped to human chromosome 12p12.1. GS or GYS exists in two isoforms of GYS-1, found in muscle and GYS-2, which is specific to the liver. The muscle GS form is also expressed in several tissues, including adipose tissue, kidney, spleen and in the nervous system.

Specificity

Anti-Glycogen Synthase 2 (C-terminal), specifically recognizes human, mouse and rat glycogen synthase 2.

Immunogen

synthetic peptide corresponding to a sequence located at the C-terminus of human glycogen synthase 2 (GYS2), conjugated to KLH. The corresponding sequence is highly conserved in rat and mouse GYS2 (84% identity).

Application

Anti-Glycogen Synthase 2 (C-terminal) antibody may be used for immunoblotting at a working concentration of 1.5-3.0 μg/ml using S1 extracts of mouse liver, rat liver and HEK-293T cells over expressing human GYS2.

Biochem/physiol Actions

Glycogen synthase catalyzes the incorporation of α-1,4-linked glucose units into glycogen chains.

Physical form

Solution in 0.01 M phos­phate buffered saline, pH 7.4, containing 15 mM sodium azide.

Storage and Stability

For continuous use, store at 2-8 °C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing, or storage in “frost-free” freezers,is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilutions should be discarded if not used within 12 hours.

Disclaimer

Unless otherwise stated in our catalog, our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Emili Cid et al.
The FEBS journal, 272(12), 3197-3213 (2005-06-16)
Muscle glycogen synthase (MGS) presents a nuclear speckled pattern in primary cultured human muscle and in 3T3-L1 cells deprived of glucose and with depleted glycogen reserves. Nuclear accumulation of the enzyme correlates inversely with cellular glycogen content. Although the glucose-induced
Glycogen Is Synthesized and Degraded by Different Pathways
Biochemistry null
Xiaohong Han et al.
Frontiers in oncology, 9, 556-556 (2019-08-27)
Background: Lung adenocarcinoma (LUAD) possesses a poor prognosis with a low 5-year survival rate even for stages I-III resected patients, it is thus critical to understand the determinants that affect the survival and discover new potentially prognostic biomarkers. Somatic copy
Alexander von Wilamowitz-Moellendorff et al.
Diabetes, 62(12), 4070-4082 (2013-08-31)
The liver responds to an increase in blood glucose levels in the postprandial state by uptake of glucose and conversion to glycogen. Liver glycogen synthase (GYS2), a key enzyme in glycogen synthesis, is controlled by a complex interplay between the

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service